Earnings NewsCellectis Non-GAAP EPS of -$0.55 misses by $0.13, revenue of $3.56M misses by $2.54MMay 04, 2023 5:33 PM ETCellectis S.A. (CLLS)By: Pranav Ghumatkar, SA News Editor Cellectis press release (NASDAQ:CLLS): Q1 Non-GAAP EPS of -$0.55 misses by $0.13. Revenue of $3.56M (-7.0% Y/Y) misses by $2.54M. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.More Trending NewsHedge funds ease up on Magnificent 7 bingeBristol Myers expands partnership with Avidity in $2.3B dealS&P, Nasdaq, Dow futures steady with more housing, consumer data aheadAdobe, Figma deal likely to result in 'substantial lessening of competition'Biggest stock movers today: Carlyle Group, Zscaler and moreSee More »About CLLSSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgCLLS--Cellectis S.A.IPHA--Innate Pharma S.A.HARP--Harpoon Therapeutics, Inc.VNDA--Vanda Pharmaceuticals Inc.MESO--Mesoblast LimitedCompareTrending AnalysisTrending News